Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
Mukulika Bose(University of North Carolina at Charlotte), Pinku Mukherjee(University of North Carolina at Charlotte), Mohammad Ahmad(University of North Carolina at Charlotte), Mahboubeh Yazdanifar(Stanford University), Priyanka Lala(University of North Carolina at Charlotte), Sritama Nath(University of North Carolina at Charlotte), Sophia Shwartz(University of North Carolina at Charlotte), Ru Zhou(University of British Columbia), Cory Brouwer(University of North Carolina at Charlotte), Priyanka Grover(University of North Carolina at Charlotte), Alexa Sanders(University of North Carolina at Charlotte)
Cited by 22
Related Papers
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
|Pharmacology & Therapeutics|2016|921
MUC1: a multifaceted oncoprotein with a key role in cancer progression
|Trends in Molecular Medicine|2014|854
MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
|Oncogene|2010|269
MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes
|Oncogenesis|2013|176
Discovery of 1-{(3<i>R</i>,4<i>R</i>)-3-[({5-Chloro-2-[(1-methyl-1<i>H</i>-pyrazol-4-yl)amino]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
|Journal of Medicinal Chemistry|2016|93